Toxicity Weighting for Human Biomonitoring Mixture Risk Assessment: A Proof of Concept

Chemical mixture risk assessment has, in the past, primarily focused on exposures quantified in the external environment. Assessing health risks using human biomonitoring (HBM) data provides information on the internal concentration, from which a dose can be derived, of chemicals to which human popu...

Full description

Bibliographic Details
Main Authors: Miranda M. Loh, Phillipp Schmidt, Yvette Christopher de Vries, Nina Vogel, Marike Kolossa-Gehring, Jelle Vlaanderen, Erik Lebret, Mirjam Luijten
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Toxics
Subjects:
Online Access:https://www.mdpi.com/2305-6304/11/5/408
_version_ 1797598214656884736
author Miranda M. Loh
Phillipp Schmidt
Yvette Christopher de Vries
Nina Vogel
Marike Kolossa-Gehring
Jelle Vlaanderen
Erik Lebret
Mirjam Luijten
author_facet Miranda M. Loh
Phillipp Schmidt
Yvette Christopher de Vries
Nina Vogel
Marike Kolossa-Gehring
Jelle Vlaanderen
Erik Lebret
Mirjam Luijten
author_sort Miranda M. Loh
collection DOAJ
description Chemical mixture risk assessment has, in the past, primarily focused on exposures quantified in the external environment. Assessing health risks using human biomonitoring (HBM) data provides information on the internal concentration, from which a dose can be derived, of chemicals to which human populations are exposed. This study describes a proof of concept for conducting mixture risk assessment with HBM data, using the population-representative German Environmental Survey (GerES) V as a case study. We first attempted to identify groups of correlated biomarkers (also known as ‘communities’, reflecting co-occurrence patterns of chemicals) using a network analysis approach (<i>n</i> = 515 individuals) on 51 chemical substances in urine. The underlying question is whether the combined body burden of multiple chemicals is of potential health concern. If so, subsequent questions are which chemicals and which co-occurrence patterns are driving the potential health risks. To address this, a biomonitoring hazard index was developed by summing over hazard quotients, where each biomarker concentration was weighted (divided) by the associated HBM health-based guidance value (HBM-HBGV, HBM value or equivalent). Altogether, for 17 out of the 51 substances, health-based guidance values were available. If the hazard index was higher than 1, then the community was considered of potential health concern and should be evaluated further. Overall, seven communities were identified in the GerES V data. Of the five mixture communities where a hazard index was calculated, the highest hazard community contained N-Acetyl-S-(2-carbamoyl-ethyl)cysteine (AAMA), but this was the only biomarker for which a guidance value was available. Of the other four communities, one included the phthalate metabolites mono-isobutyl phthalate (MiBP) and mono-n-butyl phthalate (MnBP) with high hazard quotients, which led to hazard indices that exceed the value of one in 5.8% of the participants included in the GerES V study. This biological index method can put forward communities of co-occurrence patterns of chemicals on a population level that need further assessment in toxicology or health effects studies. Future mixture risk assessment using HBM data will benefit from additional HBM health-based guidance values based on population studies. Additionally, accounting for different biomonitoring matrices would provide a wider range of exposures. Future hazard index analyses could also take a common mode of action approach, rather than the more agnostic and non-specific approach we have taken in this proof of concept.
first_indexed 2024-03-11T03:16:11Z
format Article
id doaj.art-34749a22e4ca473db4054ce212ab2961
institution Directory Open Access Journal
issn 2305-6304
language English
last_indexed 2024-03-11T03:16:11Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Toxics
spelling doaj.art-34749a22e4ca473db4054ce212ab29612023-11-18T03:32:16ZengMDPI AGToxics2305-63042023-04-0111540810.3390/toxics11050408Toxicity Weighting for Human Biomonitoring Mixture Risk Assessment: A Proof of ConceptMiranda M. Loh0Phillipp Schmidt1Yvette Christopher de Vries2Nina Vogel3Marike Kolossa-Gehring4Jelle Vlaanderen5Erik Lebret6Mirjam Luijten7Institute of Occupational Medicine—IOM, Edinburgh EH14 4AP, UKGerman Environment Agency (UBA), 14195 Berlin, GermanyInstitute of Occupational Medicine—IOM, Edinburgh EH14 4AP, UKGerman Environment Agency (UBA), 14195 Berlin, GermanyGerman Environment Agency (UBA), 14195 Berlin, GermanyInstitute for Risk Assessment Sciences (IRAS), Utrecht University, 3584 CM Utrecht, The NetherlandsInstitute for Risk Assessment Sciences (IRAS), Utrecht University, 3584 CM Utrecht, The NetherlandsCenter for Health Protection, National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The NetherlandsChemical mixture risk assessment has, in the past, primarily focused on exposures quantified in the external environment. Assessing health risks using human biomonitoring (HBM) data provides information on the internal concentration, from which a dose can be derived, of chemicals to which human populations are exposed. This study describes a proof of concept for conducting mixture risk assessment with HBM data, using the population-representative German Environmental Survey (GerES) V as a case study. We first attempted to identify groups of correlated biomarkers (also known as ‘communities’, reflecting co-occurrence patterns of chemicals) using a network analysis approach (<i>n</i> = 515 individuals) on 51 chemical substances in urine. The underlying question is whether the combined body burden of multiple chemicals is of potential health concern. If so, subsequent questions are which chemicals and which co-occurrence patterns are driving the potential health risks. To address this, a biomonitoring hazard index was developed by summing over hazard quotients, where each biomarker concentration was weighted (divided) by the associated HBM health-based guidance value (HBM-HBGV, HBM value or equivalent). Altogether, for 17 out of the 51 substances, health-based guidance values were available. If the hazard index was higher than 1, then the community was considered of potential health concern and should be evaluated further. Overall, seven communities were identified in the GerES V data. Of the five mixture communities where a hazard index was calculated, the highest hazard community contained N-Acetyl-S-(2-carbamoyl-ethyl)cysteine (AAMA), but this was the only biomarker for which a guidance value was available. Of the other four communities, one included the phthalate metabolites mono-isobutyl phthalate (MiBP) and mono-n-butyl phthalate (MnBP) with high hazard quotients, which led to hazard indices that exceed the value of one in 5.8% of the participants included in the GerES V study. This biological index method can put forward communities of co-occurrence patterns of chemicals on a population level that need further assessment in toxicology or health effects studies. Future mixture risk assessment using HBM data will benefit from additional HBM health-based guidance values based on population studies. Additionally, accounting for different biomonitoring matrices would provide a wider range of exposures. Future hazard index analyses could also take a common mode of action approach, rather than the more agnostic and non-specific approach we have taken in this proof of concept.https://www.mdpi.com/2305-6304/11/5/408human biomonitoring (HBM)chemical mixturesmixture risk assessmenttoxicity weightinghealth-based guidance value (HBGV)hazard quotient (HQ)
spellingShingle Miranda M. Loh
Phillipp Schmidt
Yvette Christopher de Vries
Nina Vogel
Marike Kolossa-Gehring
Jelle Vlaanderen
Erik Lebret
Mirjam Luijten
Toxicity Weighting for Human Biomonitoring Mixture Risk Assessment: A Proof of Concept
Toxics
human biomonitoring (HBM)
chemical mixtures
mixture risk assessment
toxicity weighting
health-based guidance value (HBGV)
hazard quotient (HQ)
title Toxicity Weighting for Human Biomonitoring Mixture Risk Assessment: A Proof of Concept
title_full Toxicity Weighting for Human Biomonitoring Mixture Risk Assessment: A Proof of Concept
title_fullStr Toxicity Weighting for Human Biomonitoring Mixture Risk Assessment: A Proof of Concept
title_full_unstemmed Toxicity Weighting for Human Biomonitoring Mixture Risk Assessment: A Proof of Concept
title_short Toxicity Weighting for Human Biomonitoring Mixture Risk Assessment: A Proof of Concept
title_sort toxicity weighting for human biomonitoring mixture risk assessment a proof of concept
topic human biomonitoring (HBM)
chemical mixtures
mixture risk assessment
toxicity weighting
health-based guidance value (HBGV)
hazard quotient (HQ)
url https://www.mdpi.com/2305-6304/11/5/408
work_keys_str_mv AT mirandamloh toxicityweightingforhumanbiomonitoringmixtureriskassessmentaproofofconcept
AT phillippschmidt toxicityweightingforhumanbiomonitoringmixtureriskassessmentaproofofconcept
AT yvettechristopherdevries toxicityweightingforhumanbiomonitoringmixtureriskassessmentaproofofconcept
AT ninavogel toxicityweightingforhumanbiomonitoringmixtureriskassessmentaproofofconcept
AT marikekolossagehring toxicityweightingforhumanbiomonitoringmixtureriskassessmentaproofofconcept
AT jellevlaanderen toxicityweightingforhumanbiomonitoringmixtureriskassessmentaproofofconcept
AT eriklebret toxicityweightingforhumanbiomonitoringmixtureriskassessmentaproofofconcept
AT mirjamluijten toxicityweightingforhumanbiomonitoringmixtureriskassessmentaproofofconcept